Sera Prognostics, Inc. financial data

Symbol
SERA on Nasdaq
Industry
Services-Medical Laboratories
Location
2749 E. Parleys Way, Suite 200, Salt Lake City, Utah
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 245 % -59.7%
Debt-to-equity 33.4 % +118%
Return On Equity -46.7 % -6.04%
Return On Assets -35 % +8.35%
Operating Margin -33.1K % -179%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 91.7M USD +134%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 32.9M shares +5.97%
Weighted Average Number of Shares Outstanding, Diluted 32.9M shares +5.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 107K USD -71.5%
Research and Development Expense 15.5M USD +0.46%
Selling and Marketing Expense 4.99M USD -57.4%
General and Administrative Expense 14.9M USD -14.2%
Operating Income (Loss) -35.4M USD +20.3%
Nonoperating Income (Expense) 3.89M USD +34.2%
Net Income (Loss) Attributable to Parent -31.5M USD +24.1%
Earnings Per Share, Basic -0.98 USD/shares +26.9%
Earnings Per Share, Diluted -0.98 USD/shares +26.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.66M USD -85.6%
Marketable Securities, Current 46.3M USD +46.7%
Accounts Receivable, after Allowance for Credit Loss, Current 101K USD -38%
Assets, Current 51.5M USD -20%
Operating Lease, Right-of-Use Asset 902K USD -37.7%
Other Assets, Noncurrent 1.71M USD +11.1%
Assets 84.9M USD -12.2%
Accounts Payable, Current 952K USD -23.5%
Contract with Customer, Liability, Current 20.2M USD +124%
Liabilities, Current 24.8M USD +74.6%
Operating Lease, Liability, Noncurrent 328K USD -65%
Liabilities 25.1M USD +61.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -211K USD +68.6%
Retained Earnings (Accumulated Deficit) -263M USD -13.6%
Stockholders' Equity Attributable to Parent 59.8M USD -26.4%
Liabilities and Equity 84.9M USD -12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.99M USD
Net Cash Provided by (Used in) Financing Activities 1.05M USD
Net Cash Provided by (Used in) Investing Activities -5.69M USD -345%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.66M USD -85.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD -43.8%
Deferred Tax Assets, Valuation Allowance 64.9M USD +19%
Deferred Tax Assets, Gross 65.2M USD +18.7%
Operating Lease, Liability 938K USD -36.9%
Payments to Acquire Property, Plant, and Equipment 15K USD -61.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -31.1M USD +25%
Lessee, Operating Lease, Liability, to be Paid 989K USD -39.2%
Operating Lease, Liability, Current 610K USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 666K USD +3.1%
Operating Lease, Weighted Average Discount Rate, Percent 7.5 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 51K USD -63.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 53.1M USD +13.7%
Unrecognized Tax Benefits 2.57M USD +26.9%
Operating Lease, Payments 638K USD +2.74%
Additional Paid in Capital 323M USD +3.09%
Depreciation, Depletion and Amortization 876K USD +5.8%
Deferred Tax Assets, Net of Valuation Allowance 310K USD -27.7%
Share-based Payment Arrangement, Expense 6.25M USD +16.4%
Interest Expense 8K USD -42.9%